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Little is known about sex difference of middle-term mortality rates in
patients surviving an ACS and about comparison with mortality rates in the
corresponding healthy population. Our aims were: 1/to review the sex differ-
ence mortality at short-term (28 day) in ACS patients, 2/to describe short-term
mortality in relation with middle-term mortality (4 years), 3/to compare sex
difference of middle-term mortality in patients surviving an ACS with the cor-
responding population. 6022 patients hospitalized for a first ACS registered in
the Strasbourg (BR), Lille and Toulouse (HG) MONICA registries, between
2009 and 2011 were included. ACS were defined as STEMI, NSTEMI, or
unstable angina (UA). Mean follow-up was 50.3 months. 3025 patients
(50.2%) were STEMI, 1571 (26.1%) NSTEMI and 1426 (23.6%) UA. 
Short-term mortality was 6.7% in men vs 9.0% in women for STEMI
(p=0.05), 4.7% vs 4.2% for NSTEMI (p=0.67) and 5.2% vs 6.6% for UA
(p=0.29). Middle-term mortality was 7.4% in men and 8.5% in women for
STEMI (p=0.39), 11.5% vs 11.9% for NSTEMI (p=0.82) and 8.6% vs 10.9%
for UA (p=0.20). The small higher short-term and middle-term mortality in
women was removed after adjustment for age and center. In men the middle-
term risk of death for STEMI compared with the corresponding population was
3.05 [2.32-4.02] in HG, 2.88 [2.25-3.68] in BR and 2.34 [1.83-2.99] in Lille. In
women the risk of death was 6.80 [4.03-11.5], 5.04 [3.04-8.37] and 6.40 [4.28-
9.58] in HG, BR and Lille respectively. Considering males and females together,
middle-term mortality of STEMI for HG was in relation to the regional popula-
tion 3.26 [2.56-4.15] and to the French population 4.17 [3.27-5.32], for BR 3.53
[2.83-4.41] vs 3.74 [6.00-4.67] and for Lille 4.40 [3.57-5.43] vs 3.42 [2.78-
4.22]. Short-term and middle-term mortality were similar in men and women. In
patients surviving an ACS, middle-term mortality was, comparatively to the cor-
responding population, from 2 to 3 times higher in women than in men.
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The “Charlie Hebdo attack” in the morning of 7 January 2015 opened a
3 days series of terror attacks across Paris region. As France pays homage
to victims, local media dedicated a too large part of their programming to a
meticulouse coverage of the attacks. We retrospectively analized the activity
of our Chest Pain Unit during January 2015 in Toulouse (France) hypothe-
sizing that emotional stress could have triggered increased rate of cardiovas-
cular–related admission. In January 2015 a total of 346 patients were
referred to our Chest Pain Unit. Among them, 162 where hospitalized and
spent at least one night in hospital; 184 were discharged, we excluded car-
diovascular etiologies for their chest pain. We observed a higher rate of hos-
pitalizations when comparing the three days of attaks (7-9/01/15) with rate
of admission for the whole month of January 2015 and 2014. During these
3 days, the incidence of daily admission for cardiovascular events requiring
hospitalization raised by more than 75% (4.85 vs 8,67; p=0.0025; +78.4%;
IC95% 1.44-6.15) if compared with the daily rate for the rest of January
2015. We obtained similar data when comparing rate of daily hospitaliza-
tions with the same week-days of the following week (3.67 vs 8,67;
p=0.0061; +136.2%; IC95%=2.38-7.62), or also the year before at the same
time (year 2014). We observed a significant decrease 3 days after the attacks
(From 8.67 to 4.67; p=0.0058; –46.1%; IC95%=1.77-6.23). Furthermore we
analysed more specifically cardiovascular causes and we observed a signif-
icant increase in comparison with the whole month of january of the inci-
dence of STEMI (+180%, p=0,029), NSTEMI (+60,9%, p=0,014;),
symptomatic cardiac arrhythmias (+71,9%, p=0,027;), and of heart failure
(+86,7%, p=0,035;). Our data provides the evidence that a high stressful
experience as a terrorist attack intensively relayed by the media induces sig-
nificant admission for chest pain leading to hospitalisation for cardiovas-
cular events.
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Background A sizeable proportion of patients treated with PCI are unable
to take dual antiplatelet therapy (DAPT) for the guideline-recommended
time period of 6-12 months. Optimal treatment of pts at high bleeding risk
thus remains uncertain. The BioFreedom™ DCS (Biosensors, Europe SA,
Abstract 0112 – Table: Evolution of outcomes from 1995 to 2010 across age 
groups
<75 years (n=7.221)
1995-2000-2005-2010
75 years (n=3.389)
1995-2000-2005-2010
VF 4.0 – 2.3 – 1.5 – 1.2% 4.6 – 4.9 – 2.0 – 1.0%
AF 7.7 – 5.0 – 3.7 – 2.9% 21.5 – 16.8 – 9.5 – 10.1%
Reinfarction NA – 2.3 – 1.5 – 0.8% NA – 2.9 – 2.4 – 1.8%
Stroke NA – 0.7 – 0.7 – 0.4% NA – 1.6 – 1.4 – 0.5%
Shock 4.7 – 4.4 – 4.0 – 2.7% 11.6 – 13.6 – 9.3 – 6.7%
30-day death 7.2 – 4.8 – 2.9 – 1.4% 25.0 – 16.8 – 13.0 – 8.4%
One-year death 10.9 – 8.8 – 5.9 – 3.9% 36.2 – 30.0 – 26.9 – 
20 0%
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